2

Remote Biotech Investment Jobs (NOW HIRING)

... biotechnology or healthcare coverage. This is a remote role reporting to the Chief Financial ... investment banking, corporate strategy, business development, corporate communications, or a ...

The Biotech/Pharma Key Account Manager is a highly specialized technical sales role responsible for ... remote, and ZMCC formats to maximize return on investment. * Work closely with e-commerce ...

Headquartered in San Francisco, our investors include Benchmark , General Catalyst , Peter Thiel ... Remote Duration: 1-2 week pilot Commitment: 10-20 hours Role Responsibilities * Create and critique ...

Validation Engineer I

San Francisco, CA ยท Remote

$20 - $23/hr

This is a remote position. PSC Biotech provides the life sciences with essential services to ensure ... investing in our employees who enable our company to fulfill our mission and achieve success. We ...

next page

Showing results 1-20

Remote Biotech Investment information

See salary details

$22K

$97.1K

$213.5K

How much do remote biotech investment jobs pay per year?

As of Aug 22, 2026, the average yearly pay for remote biotech investment in the United States is $97,073.00, according to ZipRecruiter salary data. Most workers in this role earn between $65,000.00 and $117,500.00 per year, depending on experience, location, and employer.

What is a remote biotech investment professional?

A Remote Biotech Investment professional is someone who specializes in evaluating, analyzing, and managing investments in biotechnology companies while working remotely, often from home or another non-office location. Their role includes researching biotech industry trends, assessing company financials and scientific developments, and making recommendations or decisions about where to allocate investment capital. This job typically requires a strong background in both finance and life sciences, as well as the ability to work independently and communicate effectively with colleagues and clients online. Professionals in this field may work for venture capital firms, investment banks, private equity, or as independent consultants.

How do remote biotech investment professionals typically collaborate with scientific and financial teams to evaluate potential opportunities?

In remote biotech investment roles, professionals often collaborate closely with both scientific experts and financial analysts to assess the viability of potential investments. This usually involves regular virtual meetings to review scientific data, discuss market trends, and analyze company financials. Tools like video conferencing, cloud-based data rooms, and collaborative project management platforms are commonly used to facilitate seamless communication. Successful professionals are proactive in seeking input from cross-functional teams to ensure well-rounded investment decisions, despite the physical distance.

What are the key skills and qualifications needed to thrive in remote biotech investment, and why are they important?

To excel in Remote Biotech Investment, you need a strong background in finance, biotechnology, and market analysis, often supported by a degree in finance, life sciences, or a related field. Familiarity with financial modeling tools, due diligence software, and platforms like Bloomberg Terminal or PitchBook is typically required. Excellent analytical thinking, communication, and self-motivation are standout soft skills for building client relationships and making informed investment decisions remotely. These skills and qualities are essential for accurately assessing biotech ventures, managing risks, and driving profitable investment outcomes in a dynamic, remote environment.

What is the difference between Remote Biotech Investment vs Remote Biotech Research Associate?

AspectRemote Biotech InvestmentRemote Biotech Research Associate
Required CredentialsFinance or Business degree, investment certificationsBiology or Life Sciences degree, research experience
Work EnvironmentFinancial firms, investment firms, biotech startupsResearch labs, biotech companies, academic institutions
Industry UsageInvestment analysis, funding decisions, portfolio managementExperimental research, data collection, lab work

Remote Biotech Investment focuses on evaluating biotech companies for funding and investment opportunities, requiring finance and industry knowledge. In contrast, Remote Biotech Research Associates conduct scientific experiments and data analysis in biotech labs. Both roles are essential in the biotech industry but serve different functions and require distinct skill sets.

More about Remote Biotech Investment jobs

What cities are hiring for Remote Biotech Investment jobs?

Cities with the most Remote Biotech Investment job openings:

What are the most commonly searched types of Biotech Investment jobs?

The most popular types of Biotech Investment jobs are:

What states have the most Remote Biotech Investment jobs?

States with the most job openings for Remote Biotech Investment jobs include:

Infographic showing various Remote Biotech Investment job openings in the United States as of August 2026, with employment types broken down into 92% Full Time, 6% Part Time, and 2% Contract. Highlights an 85% Physical, 6% Hybrid, and 9% Remote job distribution, with an average salary of $97,073 per year, or $46.7 per hour.

Remote | Biotech Investment Analyst $125-$185/hour

24-MAG LLC

Manhattan, NY โ€ข On-site, Remote

$125 - $185/hr

Part-time, Contractor

Posted 10 days ago


Job description

Consulting Opportunity in Biotech InvestmentWe are sharing a specialised part-time consulting opportunity for experienced biotech investment professionals with deep expertise in evaluating pharmaceutical assets, clinical-stage drug-development programmes, company fundamentals, and investment opportunities within the US biotech and healthcare market.This role supports an expert evaluation initiative focused on commercial drugs and drug-development programmes. Selected professionals will develop and critique structured evaluation rubrics, assess individual drug assets and the companies behind them, and apply specialist investment judgement across a focused set of biotech companies.Key ResponsibilitiesDrug Asset AssessmentEvaluate commercial and clinical-stage drug assets across different therapeutic areasAssess mechanism of action, biological rationale, clinical data, development progress, and regulatory considerationsAnalyse competitive positioning within relevant therapeutic and treatment landscapesIdentify key scientific, clinical, regulatory, and commercial value driversFlag unsupported assumptions, evidence gaps, or material risks within asset assessmentsCompany & Investment AnalysisConduct end-to-end assessments of biotech and pharmaceutical companiesEvaluate pipeline quality, company strategy, competitive differentiation, and major catalystsAssess the relationship between individual drug assets and overall company valuationReview investment-style theses for analytical strength, supporting evidence, and internal consistencyIdentify weak, overly confident, or missing assumptions within investment conclusionsApply consistent investment judgement across approximately 5โ€“10 companies during the pilotClinical & Commercial EvaluationInterpret clinical trial results and assess the strength and relevance of available evidenceEvaluate potential differentiation against existing and emerging standards of careAnalyse addressable markets, competitive dynamics, development timelines, and commercial opportunityAssess how clinical, regulatory, and market developments may affect asset and company valueDistinguish between well-supported conclusions and speculative investment assumptionsRubric Development & Expert ReviewCreate structured evaluation rubrics for biotech companies and drug-development programmesCritique existing rubrics for completeness, realism, and investment relevanceDefine criteria reflecting experienced biotech investment judgementIdentify missing considerations or weak assumptions in analytical frameworksProvide clear written reasoning supporting evaluation decisionsIdeal Profile5+ years of experience evaluating biotech, pharmaceutical, or healthcare companies or assetsProfessional experience as a biotech or healthcare investment analyst, ideally within a specialist investment fundStrong familiarity with biotech and pharmaceutical drug-development programmesExperience assessing drug assets from scientific, clinical, commercial, and investment perspectivesStrong understanding of clinical data, mechanisms of action, competitive landscapes, and biotech valuation driversAbility to evaluate both individual assets and the broader companies developing themExperience developing, reviewing, or presenting investment thesesStrong analytical judgement and ability to identify unsupported or incomplete assumptionsUS-based or possessing deep professional experience covering the US biotech and healthcare investment marketAvailability for approximately 10โ€“20 hours over an initial 1โ€“2 week pilotEngagement DetailsPart-time independent contractor engagementApproximately 10โ€“20 hours over an initial 1โ€“2 week pilotFully remote with flexible schedulingCompensation of $125โ€“$185/hourPotential for recurring project work for strong contributorsWork must be completed without using confidential or proprietary information belonging to any employer, client, fund, institution, or other third partyH1-B and STEM OPT support is unavailable for this engagementAbout the PlatformThis opportunity is available through 24-MAG LLC. We connect experienced professionals with remote consulting opportunities across technical, evaluation, and project-based workstreams.By submitting this application, you acknowledge that your information may be processed by 24-MAG LLC for recruitment and opportunity matching in accordance with our Privacy Policy.